Topic in Focus: Naloxone

AMA Ed Hub Logo
Learn more on Naloxone from AMA Ed Hub™.
Red JAMA Logo
Learn more on Naloxone from JAMA Network™.
Illustration of three physicians
6 reasons to join the AMA
Clear Search
UPDATED
·
5 MIN READ

COVID-19 policy recommendations for OUD, pain, harm reduction

Download guidance and issue brief PDFs—the AMA provides policy recommendations to help guide policymakers to reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.

series
Public Health
AMA COVID-19 Guides
·
5 MIN READ

Policy road map shows the way to end the overdose epidemic

It’s been clear for years that, to end the drug overdose epidemic, health insurance company and pharmacy benefit managers’ barriers to evidence-based treatment and non-opioid pain management must be eliminated.

Overdose Epidemic
Telemedicine appointment
·
6 MIN READ

Final 2021 Medicare pay schedule: What physicians need to know

Changes to E/M will ease documentation burdens, but final rule also includes painful pay cuts that Congress must act to avert. Learn more with the AMA.

Medicare & Medicaid
·
5 MIN READ

Overdose epidemic requires state action to remove barriers to care

AMA, Mannatt report emphasizes the increasing importance of removing barriers to evidence-based care.

Press Releases
·
4 MIN READ

Nov. 13, 2020: State Advocacy Update 

Public-private partnership seeks to build SUD treatment network throughout Georgia and more in the latest State Advocacy Update.

Advocacy Update
·
1 MIN READ

AMA statement on Justice Department settlement with Purdue Pharma

Any settlement should be used exclusively for data collection, research, education, overdose prevention, stigma elimination, and evidence-based treatment.

Press Releases
·
2 MIN READ

Aug. 28, 2020: State Advocacy Update

Select 2020 research relating to the nation’s drug overdose epidemic in the latest State Advocacy Update.

Advocacy Update
Figure sitting on park bench
·
5 MIN READ

Nation’s drug overdose epidemic requires new policy focus

The nation’s overdose epidemic is being increasingly fueled by illicitly manufactured fentanyl, psychostimulants, heroin, cocaine and drug combinations.

Overdose Epidemic
·
1 MIN READ

AMA applauds FDA for requiring naloxone information on opioid labels

The new labeling can serve as a starting point for discussion between patients and physicians about risks and benefits associated with opioids.

Press Releases